| Year |
Citation |
Score |
| 2022 |
Carmon I, Zecharyahu L, Elayyan J, Meka SRK, Reich E, Kandel L, Bilkei-Gorzo A, Zimmer A, Mechoulam R, Kravchenko-Balasha N, Dvir-Ginzberg M. HU308 Mitigates Osteoarthritis by Stimulating Sox9-Related Networks of Carbohydrate Metabolism. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. PMID 36350089 DOI: 10.1002/jbmr.4741 |
0.415 |
|
| 2019 |
Rock EM, Ayoub SM, Limebeer CL, Gene A, Wills KL, DeVuono MV, Smoum R, Di Marzo V, Lichtman AH, Mechoulam R, Parker LA. Acute naloxone-precipitated morphine withdrawal elicits nausea-like somatic behaviors in rats in a manner suppressed by N-oleoylglycine. Psychopharmacology. PMID 31712968 DOI: 10.1007/S00213-019-05373-2 |
0.304 |
|
| 2019 |
Pacher P, Kogan NM, Mechoulam R. Beyond THC and Endocannabinoids. Annual Review of Pharmacology and Toxicology. PMID 31580774 DOI: 10.1146/Annurev-Pharmtox-010818-021441 |
0.336 |
|
| 2019 |
Petrie GN, Wills KL, Piscitelli F, Smoum R, Limebeer CL, Rock EM, Humphrey AE, Sheppard-Perkins M, Lichtman AH, Mechoulam R, Di Marzo V, Parker LA. Oleoyl glycine: interference with the aversive effects of acute naloxone-precipitated MWD, but not morphine reward, in male Sprague-Dawley rats. Psychopharmacology. PMID 30993360 DOI: 10.1007/S00213-019-05237-9 |
0.354 |
|
| 2019 |
Alcina AG, Stevenson LA, Haj C, Smoum R, Mechoulam R, Hislop JN, Pertwee RG. A synthetic analogue of cannabidiolic acid that acts like a positive allosteric modulator at 5-HT1A receptors British Journal of Pharmacology. 176: 3011-3012. DOI: 10.1111/Bph.14681 |
0.349 |
|
| 2018 |
Donvito G, Piscitelli F, Muldoon P, Jackson A, Vitale RM, D'Aniello E, Giordano C, Ignatowska-Jankowska BM, Mustafa MA, Guida F, Petrie GN, Parker L, Smoum R, Sim-Selley L, Maione S, ... ... Mechoulam R, et al. N-Oleoyl-glycine reduces nicotine reward and withdrawal in mice. Neuropharmacology. PMID 29567093 DOI: 10.1016/J.Neuropharm.2018.03.020 |
0.301 |
|
| 2017 |
Pertwee RG, Rock EM, Guenther K, Limebeer CL, Stevenson LA, Haj C, Smoum R, Parker LA, Mechoulam R. Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5-HT1A receptor-mediated suppression of nausea and anxiety in rats. British Journal of Pharmacology. PMID 29057454 DOI: 10.1111/Bph.14073 |
0.346 |
|
| 2017 |
Silva NR, Gomes FV, Fonseca MD, Mechoulam R, Breuer A, Cunha TM, Guimarães FS. Antinociceptive effects of HUF-101, a fluorinated cannabidiol derivative. Progress in Neuro-Psychopharmacology & Biological Psychiatry. PMID 28720466 DOI: 10.1016/J.Pnpbp.2017.07.012 |
0.368 |
|
| 2016 |
Breuer A, Haj CG, Fogaça MV, Gomes FV, Silva NR, Pedrazzi JF, Del Bel EA, Hallak JC, Crippa JA, Zuardi AW, Mechoulam R, Guimarães FS. Fluorinated Cannabidiol Derivatives: Enhancement of Activity in Mice Models Predictive of Anxiolytic, Antidepressant and Antipsychotic Effects. Plos One. 11: e0158779. PMID 27416026 DOI: 10.1371/Journal.Pone.0158779 |
0.327 |
|
| 2016 |
Rock EM, Boulet N, Limebeer CL, Mechoulam R, Parker LA. Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats. European Journal of Pharmacology. PMID 27263826 DOI: 10.1016/J.Ejphar.2016.06.001 |
0.38 |
|
| 2015 |
Maslov LN, Khaliulin I, Zhang Y, Krylatov AV, Naryzhnaya NV, Mechoulam R, Petrocellis L, Downey JM. Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists. Journal of Cardiovascular Pharmacology and Therapeutics. PMID 26487546 DOI: 10.1177/1074248415612593 |
0.333 |
|
| 2015 |
Haj CG, Sumariwalla PF, Hanuš L, Kogan NM, Yektin Z, Mechoulam R, Feldmann M, Gallily R. HU-444, a Novel, Potent Anti-Inflammatory, Nonpsychotropic Cannabinoid. The Journal of Pharmacology and Experimental Therapeutics. 355: 66-75. PMID 26272937 DOI: 10.1124/Jpet.115.226100 |
0.338 |
|
| 2015 |
Kozela E, Haj C, Hanuš L, Chourasia M, Shurki A, Juknat A, Kaushansky N, Mechoulam R, Vogel Z. HU-446 and HU-465, Derivatives of the Non-psychoactive Cannabinoid Cannabidiol, Decrease the Activation of Encephalitogenic T Cells. Chemical Biology & Drug Design. PMID 26259697 DOI: 10.1111/Cbdd.12637 |
0.346 |
|
| 2015 |
Smoum R, Baraghithy S, Chourasia M, Breuer A, Mussai N, Attar-Namdar M, Kogan NM, Raphael B, Bolognini D, Cascio MG, Marini P, Pertwee RG, Shurki A, Mechoulam R, Bab I. CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency. Proceedings of the National Academy of Sciences of the United States of America. 112: 8774-9. PMID 26124120 DOI: 10.1073/Pnas.1503395112 |
0.374 |
|
| 2015 |
Maccarrone M, Bab I, Bíró T, Cabral GA, Dey SK, Di Marzo V, Konje JC, Kunos G, Mechoulam R, Pacher P, Sharkey KA, Zimmer A. Endocannabinoid signaling at the periphery: 50 years after THC. Trends in Pharmacological Sciences. 36: 277-96. PMID 25796370 DOI: 10.1016/J.Tips.2015.02.008 |
0.446 |
|
| 2015 |
Mann A, Smoum R, Trembovler V, Alexandrovich A, Breuer A, Mechoulam R, Shohami E. Palmitoyl Serine: An Endogenous Neuroprotective Endocannabinoid-Like Entity After Traumatic Brain Injury. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 10: 356-63. PMID 25721934 DOI: 10.1007/S11481-015-9595-Z |
0.353 |
|
| 2015 |
Wasserman E, Tam J, Mechoulam R, Zimmer A, Maor G, Bab I. CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9-tetrahydrocannabinol. Annals of the New York Academy of Sciences. 1335: 110-9. PMID 25573322 DOI: 10.1111/Nyas.12642 |
0.501 |
|
| 2014 |
Mechoulam R, Hanuš LO, Pertwee R, Howlett AC. Early phytocannabinoid chemistry to endocannabinoids and beyond Nature Reviews Neuroscience. 15: 757-764. PMID 25315390 DOI: 10.1038/Nrn3811 |
0.31 |
|
| 2013 |
Espejo-Porras F, Fernández-Ruiz J, Pertwee RG, Mechoulam R, García C. Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors. Neuropharmacology. 75: 155-63. PMID 23924692 DOI: 10.1016/J.Neuropharm.2013.07.024 |
0.366 |
|
| 2013 |
Cohen-Yeshurun A, Willner D, Trembovler V, Alexandrovich A, Mechoulam R, Shohami E, Leker RR. N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury Journal of Cerebral Blood Flow and Metabolism. 33: 1242-1250. PMID 23695434 DOI: 10.1038/Jcbfm.2013.75 |
0.317 |
|
| 2013 |
Mechoulam R, Parker LA. The endocannabinoid system and the brain Annual Review of Psychology. 64: 21-47. PMID 22804774 DOI: 10.1146/Annurev-Psych-113011-143739 |
0.326 |
|
| 2013 |
Fernández-Ruiz J, Sagredo O, Pazos MR, García C, Pertwee R, Mechoulam R, Martínez-Orgado J. Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? British Journal of Clinical Pharmacology. 75: 323-33. PMID 22625422 DOI: 10.1111/J.1365-2125.2012.04341.X |
0.366 |
|
| 2013 |
Maslov LN, Lishmanov YB, Oeltgen P, Pei JM, Krylatov AV, Barzakh EI, Portnichenko AG, Mechoulam R. Effects of preconditioning on coronary perfusion in cardiac ischemia and reperfusion Neuroscience and Behavioral Physiology. 43: 1039-1048. DOI: 10.1007/S11055-013-9848-3 |
0.318 |
|
| 2013 |
Maslov LN, Headrick JP, Mechoulam R, Krylatov AV, Lishmanov AY, Barzakh EI, Naryzhnaya NV, Zhang Y. The role of receptor transactivation in the cardioprotective effects of preconditioning and postconditioning Neuroscience and Behavioral Physiology. 43: 1015-1022. DOI: 10.1007/S11055-013-9844-7 |
0.355 |
|
| 2012 |
Limebeer CL, Rock EM, Mechoulam R, Parker LA. The anti-nausea effects of CB1 agonists are mediated by an action at the visceral insular cortex British Journal of Pharmacology. 167: 1126-1136. PMID 22671779 DOI: 10.1111/J.1476-5381.2012.02066.X |
0.376 |
|
| 2012 |
Sticht MA, Long JZ, Rock EM, Limebeer CL, Mechoulam R, Cravatt BF, Parker LA. Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2-arachidonoyl glycerol attenuates nausea in rats. British Journal of Pharmacology. 165: 2425-35. PMID 21470205 DOI: 10.1111/J.1476-5381.2011.01407.X |
0.365 |
|
| 2011 |
Bab I, Smoum R, Bradshaw H, Mechoulam R. Skeletal lipidomics: Regulation of bone metabolism by fatty acid amide family British Journal of Pharmacology. 163: 1441-1446. PMID 21557736 DOI: 10.1111/J.1476-5381.2011.01474.X |
0.315 |
|
| 2011 |
Fernández-Ruiz J, Moreno-Martet M, Rodríguez-Cueto C, Palomo-Garo C, Gómez-Cañas M, Valdeolivas S, Guaza C, Romero J, Guzmán M, Mechoulam R, Ramos JA. Prospects for cannabinoid therapies in basal ganglia disorders. British Journal of Pharmacology. 163: 1365-78. PMID 21545415 DOI: 10.1111/J.1476-5381.2011.01365.X |
0.323 |
|
| 2011 |
Cohen-Yeshurun A, Trembovler V, Alexandrovich A, Ryberg E, Greasley PJ, Mechoulam R, Shohami E, Leker RR. N-arachidonoyl-L-serine is neuroprotective after traumatic brain injury by reducing apoptosis Journal of Cerebral Blood Flow and Metabolism. 31: 1768-1777. PMID 21505478 DOI: 10.1038/Jcbfm.2011.53 |
0.342 |
|
| 2011 |
Di Marzo V, Piscitelli F, Mechoulam R. Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes. Handbook of Experimental Pharmacology. 75-104. PMID 21484568 DOI: 10.1007/978-3-642-17214-4_4 |
0.301 |
|
| 2011 |
Shohami E, Cohen-Yeshurun A, Magid L, Algali M, Mechoulam R. Endocannabinoids and traumatic brain injury. British Journal of Pharmacology. 163: 1402-10. PMID 21418185 DOI: 10.1111/J.1476-5381.2011.01343.X |
0.329 |
|
| 2011 |
MartÃn-Moreno AM, Reigada D, RamÃrez BG, Mechoulam R, Innamorato N, Cuadrado A, de Ceballos ML. Cannabidiol and other cannabinoids reduce microglial activation in vitro and in vivo: relevance to Alzheimer's disease. Molecular Pharmacology. 79: 964-73. PMID 21350020 DOI: 10.1124/Mol.111.071290 |
0.366 |
|
| 2011 |
Pacher P, Mechoulam R. Is lipid signaling through cannabinoid 2 receptors part of a protective system? Progress in Lipid Research. 50: 193-211. PMID 21295074 DOI: 10.1016/J.Plipres.2011.01.001 |
0.361 |
|
| 2011 |
Ofek O, Attar-Namdar M, Kram V, Dvir-Ginzberg M, Mechoulam R, Zimmer A, Frenkel B, Shohami E, Bab I. CB2 cannabinoid receptor targets mitogenic Gi protein-cyclin D1 axis in osteoblasts. Journal of Bone and Mineral Research : the Official Journal of the American Society For Bone and Mineral Research. 26: 308-16. PMID 20803555 DOI: 10.1002/Jbmr.228 |
0.479 |
|
| 2010 |
Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, Elphick MR, Greasley PJ, Hansen HS, Kunos G, Mackie K, Mechoulam R, Ross RA. International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CBâ‚ and CBâ‚‚. Pharmacological Reviews. 62: 588-631. PMID 21079038 DOI: 10.1124/Pr.110.003004 |
0.368 |
|
| 2010 |
Brown I, Cascio MG, Wahle KW, Smoum R, Mechoulam R, Ross RA, Pertwee RG, Heys SD. Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines. Carcinogenesis. 31: 1584-91. PMID 20660502 DOI: 10.1016/J.Ejso.2010.08.080 |
0.365 |
|
| 2010 |
Hanuš LO, Mechoulam R. Novel natural and synthetic ligands of the endocannabinoid system Current Medicinal Chemistry. 17: 1341-1359. PMID 20166928 DOI: 10.2174/092986710790980096 |
0.351 |
|
| 2010 |
Magen I, Avraham Y, Ackerman Z, Vorobiev L, Mechoulam R, Berry EM. Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT 1A receptor activation British Journal of Pharmacology. 159: 950-957. PMID 20128798 DOI: 10.1111/J.1476-5381.2009.00589.X |
0.308 |
|
| 2009 |
Izzo AA, Borrelli F, Capasso R, Di Marzo V, Mechoulam R. Non-psychotropic plant cannabinoids: new therapeutic opportunities from an ancient herb. Trends in Pharmacological Sciences. 30: 515-27. PMID 19729208 DOI: 10.1016/J.Tips.2009.07.006 |
0.354 |
|
| 2009 |
Sagredo O, González S, Aroyo I, Pazos MR, Benito C, Lastres-Becker I, Romero JP, Tolón RM, Mechoulam R, Brouillet E, Romero J, Fernández-Ruiz J. Cannabinoid CB2 receptor agonists protect the striatum against malonate toxicity: relevance for Huntington's disease. Glia. 57: 1154-67. PMID 19115380 DOI: 10.1002/Glia.20838 |
0.394 |
|
| 2009 |
Avraham Y, Zolotarev O, Grigoriadis NC, Pautahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice (American Journal of Gastroenterology (2009) 103, (3047-3056) DOI: 10.1111/j.1572-0241.2008.02155.x) American Journal of Gastroenterology. 104: 801. DOI: 10.1038/Ajg.2009.98 |
0.432 |
|
| 2009 |
Ofek O, Goldfine L, Bajayo A, Melamed E, Gabet Y, Shohami E, Mechoulam R, Bab I. Skeletal anabolic activity of cannabinoid receptor agonists Bone. 44. DOI: 10.1016/J.Bone.2009.01.092 |
0.367 |
|
| 2008 |
Avraham Y, Zolotarev O, Grigoriadis NC, Poutahidis T, Pautahidis T, Magen I, Vorobiav L, Zimmer A, Ilan Y, Mechoulam R, Berry EM. Cannabinoids and capsaicin improve liver function following thioacetamide-induced acute injury in mice. The American Journal of Gastroenterology. 103: 3047-56. PMID 19086956 DOI: 10.1111/J.1572-0241.2008.02155.X |
0.517 |
|
| 2008 |
Patinkin D, Milman G, Breuer A, Fride E, Mechoulam R. Endocannabinoids as positive or negative factors in hematopoietic cell migration and differentiation European Journal of Pharmacology. 595: 1-6. PMID 18778813 DOI: 10.1016/J.Ejphar.2008.05.002 |
0.769 |
|
| 2008 |
Moussaieff A, Rimmerman N, Bregman T, Straiker A, Felder CC, Shoham S, Kashman Y, Huang SM, Lee H, Shohami E, Mackie K, Caterina MJ, Walker JM, Fride E, Mechoulam R. Incensole acetate, an incense component, elicits psychoactivity by activating TRPV3 channels in the brain. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 3024-34. PMID 18492727 DOI: 10.1096/Fj.07-101865 |
0.757 |
|
| 2008 |
Moussaieff A, Shein NA, Tsenter J, Grigoriadis S, Simeonidou C, Alexandrovich AG, Trembovler V, Ben-Neriah Y, Schmitz ML, Fiebich BL, Munoz E, Mechoulam R, Shohami E. Incensole acetate: a novel neuroprotective agent isolated from Boswellia carterii. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 28: 1341-52. PMID 18414499 DOI: 10.1038/Jcbfm.2008.28 |
0.304 |
|
| 2008 |
Palazuelos J, Davoust N, Julien B, Hatterer E, Aguado T, Mechoulam R, Benito C, Romero J, Silva A, Guzmán M, Nataf S, Galve-Roperh I. The CB(2) cannabinoid receptor controls myeloid progenitor trafficking: involvement in the pathogenesis of an animal model of multiple sclerosis. The Journal of Biological Chemistry. 283: 13320-9. PMID 18334483 DOI: 10.1074/Jbc.M707960200 |
0.362 |
|
| 2008 |
Bermúdez-Silva FJ, Suárez J, Baixeras E, Cobo N, Bautista D, Cuesta-Muñoz AL, Fuentes E, Juan-Pico P, Castro MJ, Milman G, Mechoulam R, Nadal A, RodrÃguez de Fonseca F. Presence of functional cannabinoid receptors in human endocrine pancreas. Diabetologia. 51: 476-87. PMID 18092149 DOI: 10.1007/S00125-007-0890-Y |
0.314 |
|
| 2008 |
McHugh D, Tanner C, Mechoulam R, Pertwee RG, Ross RA. Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2. Molecular Pharmacology. 73: 441-50. PMID 17965195 DOI: 10.1124/Mol.107.041863 |
0.361 |
|
| 2008 |
Tam J, Trembovler V, Di Marzo V, Petrosino S, Leo G, Alexandrovich A, Regev E, Casap N, Shteyer A, Ledent C, Karsak M, Zimmer A, Mechoulam R, Yirmiya R, Shohami E, et al. The cannabinoid CB1 receptor regulates bone formation by modulating adrenergic signaling. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 22: 285-94. PMID 17704191 DOI: 10.1096/Fj.06-7957Com |
0.481 |
|
| 2007 |
Mechoulam R, Shohami E. Endocannabinoids and traumatic brain injury. Molecular Neurobiology. 36: 68-74. PMID 17952651 DOI: 10.1007/S12035-007-8008-6 |
0.309 |
|
| 2007 |
Moussaieff A, Shohami E, Kashman Y, Fride E, Schmitz ML, Renner F, Fiebich BL, Munoz E, Ben-Neriah Y, Mechoulam R. Incensole acetate, a novel anti-inflammatory compound isolated from Boswellia resin, inhibits nuclear factor-kappa B activation. Molecular Pharmacology. 72: 1657-64. PMID 17895408 DOI: 10.1124/Mol.107.038810 |
0.746 |
|
| 2007 |
Sagredo O, Ramos JA, Decio A, Mechoulam R, Fernández-Ruiz J. Cannabidiol reduced the striatal atrophy caused 3-nitropropionic acid in vivo by mechanisms independent of the activation of cannabinoid, vanilloid TRPV1 and adenosine A2A receptors. The European Journal of Neuroscience. 26: 843-51. PMID 17672854 DOI: 10.1111/J.1460-9568.2007.05717.X |
0.341 |
|
| 2007 |
Karsak M, Gaffal E, Date R, Wang-Eckhardt L, Rehnelt J, Petrosino S, Starowicz K, Steuder R, Schlicker E, Cravatt B, Mechoulam R, Buettner R, Werner S, Di Marzo V, Tüting T, et al. Attenuation of allergic contact dermatitis through the endocannabinoid system Science. 316: 1494-1497. PMID 17556587 DOI: 10.1126/Science.1142265 |
0.503 |
|
| 2007 |
García-Arencibia M, González S, de Lago E, Ramos JA, Mechoulam R, Fernández-Ruiz J. Evaluation of the neuroprotective effect of cannabinoids in a rat model of Parkinson's disease: importance of antioxidant and cannabinoid receptor-independent properties. Brain Research. 1134: 162-70. PMID 17196181 DOI: 10.1016/J.Brainres.2006.11.063 |
0.352 |
|
| 2006 |
Palazuelos J, Aguado T, Egia A, Mechoulam R, Guzmán M, Galve-Roperh I. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2405-7. PMID 17015409 DOI: 10.1096/Fj.06-6164Fje |
0.378 |
|
| 2006 |
Tam J, Ofek O, Fride E, Ledent C, Gabet Y, M̈uller R, Zimmer A, Mackie K, Mechoulam R, Shohami E, Bab I. Involvement of neuronal cannabinoid receptor CB1 in regulation of bone mass and bone remodeling Molecular Pharmacology. 70: 786-792. PMID 16772520 DOI: 10.1124/Mol.106.026435 |
0.765 |
|
| 2006 |
Shohami E, Mechoulam R. Multiple sclerosis may disrupt endocannabinoid brain protection mechanism. Proceedings of the National Academy of Sciences of the United States of America. 103: 6087-8. PMID 16606822 DOI: 10.1073/Pnas.0601847103 |
0.324 |
|
| 2006 |
Mechoulam R, Berry EM, Avraham Y, Di Marzo V, Fride E. Endocannabinoids, feeding and suckling - From our perspective International Journal of Obesity. 30: S24-S28. PMID 16570101 DOI: 10.1038/Sj.Ijo.0803274 |
0.759 |
|
| 2006 |
Milman G, Maor Y, Abu-Lafi S, Horowitz M, Gallily R, Batkai S, Mo FM, Offertaler L, Pacher P, Kunos G, Mechoulam R. N-arachidonoyl L-serine, an endocannabinoid-like brain constituent with vasodilatory properties. Proceedings of the National Academy of Sciences of the United States of America. 103: 2428-33. PMID 16467152 DOI: 10.1073/Pnas.0510676103 |
0.378 |
|
| 2006 |
Ofek O, Karsak M, Leclerc N, Fogel M, Frenkel B, Wright K, Tam J, Attar-Namdar M, Kram V, Shohami E, Mechoulam R, Zimmer A, Bab I. Peripheral cannabinoid receptor, CB2, regulates bone mass. Proceedings of the National Academy of Sciences of the United States of America. 103: 696-701. PMID 16407142 DOI: 10.1073/Pnas.0504187103 |
0.489 |
|
| 2006 |
Avraham Y, Israeli E, Gabbay E, Okun A, Zolotarev O, Silberman I, Ganzburg V, Dagon Y, Magen I, Vorobia L, Pappo O, Mechoulam R, Ilan Y, Berry EM. Endocannabinoids affect neurological and cognitive function in thioacetamide-induced hepatic encephalopathy in mice. Neurobiology of Disease. 21: 237-45. PMID 16102970 DOI: 10.1016/J.Nbd.2005.07.008 |
0.386 |
|
| 2005 |
Sarne Y, Mechoulam R. Cannabinoids: between neuroprotection and neurotoxicity. Current Drug Targets. Cns and Neurological Disorders. 4: 677-84. PMID 16375685 DOI: 10.2174/156800705774933005 |
0.327 |
|
| 2005 |
Unzicker C, Erberich H, Moldrich G, Woldt H, Bulla J, Mechoulam R, Ehrenreich H, Sirén AL. Hippocampal cannabinoid-1 receptor upregulation upon endothelin-B receptor deficiency: a neuroprotective substitution effect? Neurochemical Research. 30: 1305-9. PMID 16341592 DOI: 10.1007/S11064-005-8802-3 |
0.359 |
|
| 2005 |
Fride E, Suris R, Weidenfeld J, Mechoulam R. Differential response to acute and repeated stress in cannabinoid CB 1 receptor knockout newborn and adult mice Behavioural Pharmacology. 16: 431-440. PMID 16148448 DOI: 10.1097/00008877-200509000-00016 |
0.751 |
|
| 2005 |
Moussaieff A, Fride E, Amar Z, Lev E, Steinberg D, Gallily R, Mechoulam R. The Jerusalem Balsam: From the Franciscan Monastery in the old city of Jerusalem to Martindale 33 Journal of Ethnopharmacology. 101: 16-26. PMID 15963667 DOI: 10.1016/J.Jep.2005.03.028 |
0.734 |
|
| 2005 |
Pertwee RG, Thomas A, Stevenson LA, Maor Y, Mechoulam R. Evidence that (-)-7-hydroxy-4'-dimethylheptyl-cannabidiol activates a non-CB(1), non-CB(2), non-TRPV1 target in the mouse vas deferens. Neuropharmacology. 48: 1139-46. PMID 15910889 DOI: 10.1016/J.Neuropharm.2005.01.010 |
0.357 |
|
| 2005 |
Lastres-Becker I, Molina-Holgado F, Ramos JA, Mechoulam R, Fernández-Ruiz J. Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease. Neurobiology of Disease. 19: 96-107. PMID 15837565 DOI: 10.1016/J.Nbd.2004.11.009 |
0.359 |
|
| 2005 |
Hanus LO, Tchilibon S, Ponde DE, Breuer A, Fride E, Mechoulam R. Enantiomeric cannabidiol derivatives: synthesis and binding to cannabinoid receptors. Organic & Biomolecular Chemistry. 3: 1116-23. PMID 15750656 DOI: 10.1039/B416943C |
0.776 |
|
| 2005 |
Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E. CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 25: 477-84. PMID 15729296 DOI: 10.1038/Sj.Jcbfm.9600047 |
0.37 |
|
| 2005 |
Maccarrone M, Fride E, Bisogno T, Bari M, Cascio MG, Battista N, Finazzi Agrò A, Suris R, Mechoulam R, Di Marzo V. Up-regulation of the endocannabinoid system in the uterus of leptin knockout (ob/ob) mice and implications for fertility Molecular Human Reproduction. 11: 21-28. PMID 15563449 DOI: 10.1093/Molehr/Gah130 |
0.763 |
|
| 2005 |
Mechoulam R, Sumariwalla PF, Feldmann M, Gallily R. Cannabinoids in models of chronic inflammatory conditions Phytochemistry Reviews. 4: 11-18. DOI: 10.1007/S11101-004-1534-1 |
0.325 |
|
| 2004 |
Fride E, Feigin C, Ponde DE, Breuer A, Hanus L, Arshavsky N, Mechoulam R. (+)-Cannabidiol analogues which bind cannabinoid receptors but exert peripheral activity only. European Journal of Pharmacology. 506: 179-88. PMID 15588739 DOI: 10.1016/J.Ejphar.2004.10.049 |
0.793 |
|
| 2004 |
Golech SA, McCarron RM, Chen Y, Bembry J, Lenz F, Mechoulam R, Shohami E, Spatz M. Human brain endothelium: coexpression and function of vanilloid and endocannabinoid receptors. Brain Research. Molecular Brain Research. 132: 87-92. PMID 15548432 DOI: 10.1016/J.Molbrainres.2004.08.025 |
0.401 |
|
| 2004 |
Sumariwalla PF, Gallily R, Tchilibon S, Fride E, Mechoulam R, Feldmann M. A Novel Synthetic, Nonpsychoactive Cannabinoid Acid (HU-320) with Antiinflammatory Properties in Murine Collagen-Induced Arthritis Arthritis and Rheumatism. 50: 985-998. PMID 15022343 DOI: 10.1002/Art.20050 |
0.753 |
|
| 2003 |
Parker LA, Mechoulam R. Cannabinoid Agonists and Antagonists Modulate Lithium-induced Conditioned Gaping in Rats Integrative Physiological and Behavioral Science. 38: 133-145. PMID 14527182 DOI: 10.1007/Bf02688831 |
0.3 |
|
| 2003 |
Mechoulam R, Lichtman AH. Neuroscience. Stout guards of the central nervous system. Science (New York, N.Y.). 302: 65-7. PMID 14526067 DOI: 10.1126/Science.1091256 |
0.314 |
|
| 2003 |
Gilgun-Sherki Y, Melamed E, Mechoulam R, Offen D. The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats. Pharmacology & Toxicology. 93: 66-70. PMID 12899667 DOI: 10.1034/J.1600-0773.2003.930202.X |
0.313 |
|
| 2003 |
Fride E, Foox A, Rosenberg E, Faigenboim M, Cohen V, Barda L, Blau H, Mechoulam R. Milk intake and survival in newborn cannabinoid CB1 receptor knockout mice: Evidence for a "CB3" receptor European Journal of Pharmacology. 461: 27-34. PMID 12568912 DOI: 10.1016/S0014-2999(03)01295-0 |
0.784 |
|
| 2002 |
Mechoulam R, Hanuš L. Cannabidiol: An overview of some chemical and pharmacological aspects. Part I: Chemical aspects Chemistry and Physics of Lipids. 121: 35-43. PMID 12505688 DOI: 10.1016/S0009-3084(02)00144-5 |
0.301 |
|
| 2002 |
Ugdyzhekova DS, Krylatov AV, Bernatskaya NA, Maslov LN, Mechoulam R, Pertwee RG. Activation of cannabinoid receptors decreases the area of ischemic myocardial necrosis Bulletin of Experimental Biology and Medicine. 133: 125-126. PMID 12428278 DOI: 10.1023/A:1015526217332 |
0.338 |
|
| 2002 |
Mechoulam R, Parker LA, Gallily R. Cannabidiol: An overview of some pharmacological aspects Journal of Clinical Pharmacology. 42: 11S-19S. PMID 12412831 DOI: 10.1002/J.1552-4604.2002.Tb05998.X |
0.333 |
|
| 2002 |
Berry EM, Mechoulam R. Tetrahydrocannabinol and endocannabinoids in feeding and appetite Pharmacology and Therapeutics. 95: 185-190. PMID 12182965 DOI: 10.1016/S0163-7258(02)00257-7 |
0.354 |
|
| 2002 |
Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, Felder CC, Herkenham M, Mackie K, Martin BR, Mechoulam R, Pertwee RG. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacological Reviews. 54: 161-202. PMID 12037135 DOI: 10.1124/Pr.54.2.161 |
0.378 |
|
| 2002 |
Mechoulam R, Panikashvili D, Shohami E. Cannabinoids and brain injury: Therapeutic implications Trends in Molecular Medicine. 8: 58-61. PMID 11815270 DOI: 10.1016/S1471-4914(02)02276-1 |
0.326 |
|
| 2001 |
Bisogno T, Hanuš L, De Petrocellis L, Tchilibon S, Ponde DE, Brandi I, Moriello AS, Davis JB, Mechoulam R, Di Marzo V. Molecular targets for cannabidiol and its synthetic analogues: Effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide British Journal of Pharmacology. 134: 845-852. PMID 11606325 DOI: 10.1038/Sj.Bjp.0704327 |
0.35 |
|
| 2001 |
Fride E, Ginzburg Y, Breuer A, Bisogno T, Di Marzo V, Mechoulam R. Critical role of the endogenous cannabinoid system in mouse pup suckling and growth European Journal of Pharmacology. 419: 207-214. PMID 11426843 DOI: 10.1016/S0014-2999(01)00953-0 |
0.776 |
|
| 2001 |
Mechoulam R, Fride E. Physiology: A hunger for cannabinoids Nature. 410: 763+765. PMID 11298428 DOI: 10.1038/35071214 |
0.733 |
|
| 2001 |
Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, Kustanovich I, Mechoulam R. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor Proceedings of the National Academy of Sciences of the United States of America. 98: 3662-3665. PMID 11259648 DOI: 10.1073/Pnas.061029898 |
0.782 |
|
| 2000 |
Malfait AM, Gallily R, Sumariwalla PF, Malik AS, Andreakos E, Mechoulam R, Feldmann M. The nonpsychoactive cannabis constituent cannabidiol is an oral anti-arthritic therapeutic in murine collagen-induced arthritis Proceedings of the National Academy of Sciences of the United States of America. 97: 9561-9566. PMID 10920191 DOI: 10.1073/Pnas.160105897 |
0.314 |
|
| 2000 |
Shohami E, Mechoulam R. Dexanabinol (HU-211): A nonpsychotropic cannabinoid with neuroprotective properties Drug Development Research. 50: 211-215. DOI: 10.1002/1098-2299(200007/08)50:3/4<211::Aid-Ddr3>3.0.Co;2-G |
0.314 |
|
| 1999 |
Hanus L, Breuer A, Tchilibon S, Shiloah S, Goldenberg D, Horowitz M, Pertwee RG, Ross RA, Mechoulam R, Fride E. HU-308: a specific agonist for CB(2), a peripheral cannabinoid receptor. Proceedings of the National Academy of Sciences of the United States of America. 96: 14228-33. PMID 10588688 DOI: 10.1073/Pnas.96.25.14228 |
0.782 |
|
| 1999 |
Martin BR, Mechoulam R, Razdan RK. Discovery and characterization of endogenous cannabinoids. Life Sciences. 65: 573-95. PMID 10462059 DOI: 10.1016/S0024-3205(99)00281-7 |
0.384 |
|
| 1998 |
Mechoulam R, Hanuš L, Fride E. 5 Towards cannabinoid drugs - revisited Progress in Medicinal Chemistry. 35: 199-243. PMID 10795402 DOI: 10.1016/S0079-6468(08)70037-7 |
0.722 |
|
| 1998 |
Di Marzo V, Sepe N, De Petrocellis L, Berger A, Crozier G, Fride E, Mechoulam R, Beltramo M, Piomelli D. Trick or treat from food endocannabinoids? [4] (multiple letters) Nature. 396: 636-637. PMID 9872309 DOI: 10.1038/25267 |
0.745 |
|
| 1998 |
Mechoulam R, Fride E, Ben-Shabat S, Meiri U, Horowitz M. Carbachol, an acetylcholine receptor agonist, enhances production in rat aorta of 2-arachidonoyl glycerol, a hypotensive endocannabinoid European Journal of Pharmacology. 362: R1-R3. PMID 9865537 DOI: 10.1016/S0014-2999(98)00777-8 |
0.762 |
|
| 1998 |
Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z, Bisogno T, De Petrocellis L, Di Marzo V, Mechoulam R. An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity European Journal of Pharmacology. 353: 23-31. PMID 9721036 DOI: 10.1016/S0014-2999(98)00392-6 |
0.791 |
|
| 1998 |
Sulcova E, Mechoulam R, Fride E. Biphasic effects of anandamide Pharmacology Biochemistry and Behavior. 59: 347-352. PMID 9476980 DOI: 10.1016/S0091-3057(97)00422-X |
0.762 |
|
| 1997 |
Rhee MH, Vogel Z, Barg J, Bayewitch M, Levy R, Hanuš L, Breuer A, Mechoulam R. Cannabinol derivatives: Binding to cannabinoid receptors and inhibition of adenylylcyclase Journal of Medicinal Chemistry. 40: 3228-3233. PMID 9379442 DOI: 10.1021/Jm970126F |
0.357 |
|
| 1997 |
Bisogno T, Sepe N, De Petrocellis L, Mechoulam R, Di Marzo V. The sleep inducing factor oleamide is produced by mouse neuroblastoma cells Biochemical and Biophysical Research Communications. 239: 473-479. PMID 9344854 DOI: 10.1006/Bbrc.1997.7431 |
0.319 |
|
| 1997 |
Mechoulam R, Fride E, Hanuš L, Sheskin T, Bisogno T, Marzo VD, Bayewitch M, Vogel Z. Anandamide may mediate sleep induction [6] Nature. 389: 25-26. PMID 9288961 DOI: 10.1038/37891 |
0.721 |
|
| 1996 |
Mechoulam R, Ben Shabat S, Hanuš L, Fride E, Vogel Z, Bayewitch M, Sulcova AE. Endogenous cannabinoid ligands - Chemical and biological studies Journal of Lipid Mediators and Cell Signalling. 14: 45-49. PMID 8906544 DOI: 10.1016/0929-7855(96)01507-6 |
0.786 |
|
| 1996 |
Fride E, Mechoulam R. Ontogenetic development of the response to anandamide and delta 9-tetrahydrocannabinol in mice. Brain Research. Developmental Brain Research. 95: 131-4. PMID 8873985 DOI: 10.1016/0165-3806(96)00087-9 |
0.754 |
|
| 1996 |
Mechoulam R, Ben Shabat S, Hanuš L, Fride E, Bayewitch M, Vogel Z. Endogenous cannabinoid ligands Advances in Experimental Medicine and Biology. 402: 95-100. PMID 8787649 DOI: 10.1007/978-1-4613-0407-4_14 |
0.751 |
|
| 1996 |
Fride E, Mechoulam R. Developmental aspects of anandamide: ontogeny of response and prenatal exposure. Psychoneuroendocrinology. 21: 157-72. PMID 8774060 DOI: 10.1016/0306-4530(95)00039-9 |
0.77 |
|
| 1996 |
Bayewitch M, Rhee MH, Avidor-Reiss T, Breuer A, Mechoulam R, Vogel Z. (-)-Delta9-tetrahydrocannabinol antagonizes the peripheral cannabinoid receptor-mediated inhibition of adenylyl cyclase. The Journal of Biological Chemistry. 271: 9902-5. PMID 8626625 DOI: 10.1074/Jbc.271.17.9902 |
0.393 |
|
| 1996 |
Shohami E, Weidenfeld J, Ovadia H, Vogel Z, Hanuš L, Fride E, Breuer A, Ben-Shabat S, Sheskin T, Mechoulam R. Endogenous and synthetic cannabinoids: Recent advances Cns Drug Reviews. 2: 429-451. DOI: 10.1111/J.1527-3458.1996.Tb00310.X |
0.741 |
|
| 1995 |
Barg J, Fride E, Hanus L, Levy R, Matus-Leibovitch N, Heldman E, Bayewitch M, Mechoulam R, Vogel Z. Cannabinomimetic behavioral effects of and adenylate cyclase inhibition by two new endogenous anandamides. European Journal of Pharmacology. 287: 145-52. PMID 8749028 DOI: 10.1016/0014-2999(95)00487-4 |
0.773 |
|
| 1995 |
Ovadia H, Wohlman A, Mechoulam R, Weidenfeld J. Characterization of the hypothermic effect of the synthetic cannabinoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology. 34: 175-180. PMID 7617143 DOI: 10.1016/0028-3908(94)00133-D |
0.353 |
|
| 1995 |
Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, Gopher A, Almog S, Martin BR, Compton DR. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology. 50: 83-90. PMID 7605349 DOI: 10.1016/0006-2952(95)00109-D |
0.355 |
|
| 1995 |
Bayewitch M, Avidor-Reiss T, Levy R, Barg J, Mechoulam R, Vogel Z. The peripheral cannabinoid receptor: adenylate cyclase inhibition and G protein coupling. Febs Letters. 375: 143-7. PMID 7498464 DOI: 10.1016/0014-5793(95)01207-U |
0.382 |
|
| 1994 |
Weidenfeld J, Feldman S, Mechoulam R. Effect of the brain constituent anandamide, a cannabinoid receptor agonist, on the hypothalamo-pituitary-adrenal axis in the rat. Neuroendocrinology. 59: 110-112. PMID 8127398 DOI: 10.1159/000126646 |
0.353 |
|
| 1994 |
Schuel H, Goldstein E, Mechoulam R, Zimmerman AM, Zimmerman S. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, reduces sperm fertilizing capacity in sea urchins by inhibiting the acrosome reaction. Proceedings of the National Academy of Sciences of the United States of America. 91: 7678-82. PMID 8052642 DOI: 10.1073/Pnas.91.16.7678 |
0.336 |
|
| 1994 |
Mechoulam R, Hanuš L, Martin BR. Search for endogenous ligands of the cannabinoid receptor. Biochemical Pharmacology. 48: 1537-1544. PMID 7980618 DOI: 10.1016/0006-2952(94)90197-X |
0.325 |
|
| 1994 |
RodrÃguez de Fonseca F, MartÃn Calderón JL, Mechoulam R, Navarro M. Repeated stimulation of D1 dopamine receptors enhances (-)-11-hydroxy-delta 8-tetrahydrocannabinol-dimethyl-heptyl-induced catalepsy in male rats. Neuroreport. 5: 761-5. PMID 7912554 DOI: 10.1097/00001756-199403000-00006 |
0.339 |
|
| 1994 |
Wirguin I, Mechoulam R, Breuer A, Schezen E, Weidenfeld J, Brenner T. Suppression of experimetal autoimmune encephalomyelitis by cannabinoids Immunopharmacology. 28: 209-214. PMID 7852052 DOI: 10.1016/0162-3109(94)90056-6 |
0.318 |
|
| 1994 |
Mechoulam R, Vogel Z, Barg J. CNS Cannabinoid Receptors Cns Drugs. 2: 255-260. DOI: 10.2165/00023210-199402040-00001 |
0.347 |
|
| 1993 |
Vogel Z, Barg J, Levy R, Saya D, Heldman E, Mechoulam R. Anandamide, a brain endogenous compound, interacts specifically with cannabinoid receptors and inhibits adenylate cyclase. Journal of Neurochemistry. 61: 352-355. PMID 8515284 DOI: 10.1111/J.1471-4159.1993.Tb03576.X |
0.378 |
|
| 1993 |
Hanus L, Gopher A, Almog S, Mechoulam R. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor Journal of Medicinal Chemistry. 36: 3032-3034. PMID 8411021 DOI: 10.1021/Jm00072A026 |
0.379 |
|
| 1993 |
Fride E, Mechoulam R. Pharmacological activity of the cannabinoid receptor agonist, anandamide, a brain constituent. European Journal of Pharmacology. 231: 313-4. PMID 8384116 DOI: 10.1016/0014-2999(93)90468-W |
0.783 |
|
| 1993 |
Nadler V, Mechoulam R, Sokolovsky M. Blockade of45Ca2+ influx through theN-methyl-d-aspartate receptor ion channel by the non-psychoactive cannabinoid HU-211 Brain Research. 622: 79-85. PMID 8242387 DOI: 10.1016/0006-8993(93)90804-V |
0.306 |
|
| 1993 |
Nadler V, Mechoulam R, Sokolovsky M. The non-psychotropic cannabinoid (+)-(3S,4S)-7-hydroxy-Δ6-tetrahydrocannabinol 1,1-dimethylheptyl (HU-211) attenuates receptor-mediated neurotoxicity in primary cultures of rat forebrain Neuroscience Letters. 162: 43-45. PMID 8121633 DOI: 10.1016/0304-3940(93)90555-Y |
0.314 |
|
| 1992 |
Burstein SH, Audette CA, Breuer A, Devane WA, Colodner S, Doyle SA, Mechoulam R. Synthetic nonpsychotropic cannabinoids with potent antiinflammatory, analgesic, and leukocyte antiadhesion activities Journal of Medicinal Chemistry. 35: 3135-3141. PMID 1507202 DOI: 10.1021/Jm00095A007 |
0.354 |
|
| 1992 |
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R. Isolation And Structure Of A Brain Constituent That Binds To The Cannabinoid Receptor Science. 258: 1946-1949. PMID 1470919 DOI: 10.1126/Science.1470919 |
0.366 |
|
| 1992 |
Devane WA, Breuer A, Sheskin T, Järbe TU, Eisen MS, Mechoulam R. A novel probe for the cannabinoid receptor. Journal of Medicinal Chemistry. 35: 2065-9. PMID 1317925 DOI: 10.1021/Jm00089A018 |
0.357 |
|
| 1991 |
Mechoulam R, Devane WA, Breuer A, Zahalka J. A random walk through a cannabis field. Pharmacology, Biochemistry and Behavior. 40: 461-464. PMID 1806938 DOI: 10.1016/0091-3057(91)90347-5 |
0.353 |
|
| 1991 |
Martin BR, Compton DR, Thomas BF, Prescott WR, Little PJ, Razdan RK, Johnson MR, Melvin LS, Mechoulam R, Ward SJ. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacology, Biochemistry, and Behavior. 40: 471-8. PMID 1666911 DOI: 10.1016/0091-3057(91)90349-7 |
0.319 |
|
| 1991 |
Zeltser R, Seltzer Z, Eisen A, Feigenbaum JJ, Mechoulam R. Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties. Pain. 47: 95-103. PMID 1663228 DOI: 10.1016/0304-3959(91)90016-Q |
0.341 |
|
| 1990 |
Howlett AC, Champion TM, Wilken GH, Mechoulam R. Stereochemical effects of 11-OH-Δ8-tetrahydrocannabinol-dimethylheptyl to inhibit adenylate cyclase and bind to the cannabinoid receptor Neuropharmacology. 29: 161-165. PMID 2158635 DOI: 10.1016/0028-3908(90)90056-W |
0.34 |
|
| 1990 |
Eisen A, Seltzer Z, Netzach M, Zeltser R, Ginzburg R, Feigenbaum J, Richmond S, Mechoulam R. Suppression of deafferentation-induced chronic pain behavior in the rat by HU211 — An anti-nociceptive synthetic cannabinoid with nmda receptor-blocking properties Pain. 41. DOI: 10.1016/0304-3959(90)92477-8 |
0.307 |
|
| 1989 |
Feigenbaum JJ, Bergmann F, Richmond SA, Mechoulam R, Nadler V, Kloog Y, Sokolovsky M. Nonpsychotropic cannabinoid acts as a functional N-methyl-D-aspartate receptor blocker. Proceedings of the National Academy of Sciences of the United States of America. 86: 9584-7. PMID 2556719 DOI: 10.1073/Pnas.86.23.9584 |
0.34 |
|
| 1982 |
Leite JR, Carlini EA, Lander N, Mechoulam R. Anticonvulsant effects of the (-) and (+)isomers of cannabidiol and their dimethylheptyl homologs. Pharmacology. 24: 141-6. PMID 7071126 DOI: 10.1159/000137588 |
0.316 |
|
| 1980 |
Cordova T, Ayalon D, Lander N, Mechoulam R, Nir I, Puder M, Lindner HR. The ovulation blocking effect of cannabinoids: structure-activity relationships. Psychoneuroendocrinology. 5: 53-62. PMID 6248914 DOI: 10.1016/0306-4530(80)90009-8 |
0.315 |
|
| 1974 |
Houry S, Mechoulam R, Fowler PJ, Macko E, Loev B. Benzoxocin and benzoxonin derivatives. Novel groups of terpenophenols with central nervous system activity. Journal of Medicinal Chemistry. 17: 287-293. PMID 1159719 DOI: 10.1021/Jm00243A020 |
0.302 |
|
| 1965 |
Pelletier SW, Adityachaudhury N, Tomaz M, Reynolds JJ, Mechoulam R. The structure of senegenic acid, a nortriterpene artifact from Polygala senega. The Journal of Organic Chemistry. 30: 4234-47. PMID 5846174 |
0.402 |
|
| 1964 |
Sondheimer F, Mechoulam R, Sprecher M. The synthesis of 19-hydroxy-10-alpha-testosterone. Tetrahedron. 20: 2473-85. PMID 5879223 DOI: 10.1016/S0040-4020(01)90827-0 |
0.469 |
|
| 1960 |
Sondheimer F, Burstein S, Mechoulam R. Syntheses in the cardiac aglycone field. III. The conversion of a 14α- to a 14β-hydroxy group in the androstane series. The ultraviolet spectra of Δ15-androsten-17-ones Journal of the American Chemical Society. 82: 3209-3214. DOI: 10.1021/Ja01497A055 |
0.456 |
|
| 1960 |
Sondheimer F, Mechoulam R, Sprecher M. 19-hydroxy-10-isotestosterone Tetrahedron Letters. 1: 38-44. DOI: 10.1016/S0040-4039(01)99376-1 |
0.482 |
|
| 1959 |
Sondheimer F, Mechoulam R. Notes. The Dies-Alder Reaction of Steroidal 20-Methylene-Δ16-pregnene Derivatives with Maleic Anhydride Journal of Organic Chemistry. 24: 106-107. DOI: 10.1021/Jo01083A600 |
0.47 |
|
| 1958 |
Mechoulam R, Sondheimer F. The Wittig Reaction with Fluorenone. Formation of Cyclopropane Derivatives Journal of the American Chemical Society. 80: 4386-4388. DOI: 10.1021/Ja01549A069 |
0.458 |
|
| 1958 |
Sondheimer F, Mechoulam R. Further Aspects of the Wittig Reaction in the Steroid Series. 20-Dehydrocholesterol and 20-Isocholesterol Journal of the American Chemical Society. 80: 3087-3090. DOI: 10.1021/Ja01545A046 |
0.46 |
|
| 1957 |
Sondheimer F, Mechoulam R. Synthesis of Steroidal Methylene Compounds by the Wittig Reaction1 Journal of the American Chemical Society. 79: 5029-5033. DOI: 10.1021/Ja01575A054 |
0.482 |
|
| Show low-probability matches. |
